Literature DB >> 30847862

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes.

E Cipponeri1, N Vitturi1, V Mariano1, F Boscari1, S Galasso1, C Crepaldi1, G P Fadini1, S Vigili de Kreutzenberg1, M C Marescotti1, E Iori1, F Cavallin2, L Sartori3, A Baritussio3, A Avogaro1, D Bruttomesso4.   

Abstract

PURPOSE: In patients with type 1 diabetes (T1D), the prevalence of non-alcoholic fatty liver disease (NAFLD) ranges from 10 to 53% and contrasting evidence suggests that vitamin D deficiency may favor liver fat accumulation. Here, we investigated the association between vitamin D status and NAFLD in adults with T1D.
METHODS: 220 consecutive adult T1D patients on multiple daily injections or continuous subcutaneous insulin infusion and not taking calcium or vitamin D supplements were included. Patient characteristics, 25(OH)D serum levels, and metabolic parameters were analyzed. Vitamin D status was defined as sufficiency ( ≥ 75 nmol/L; 30 ng/ml), insufficiency (50-75 nmol/L; 20-30 ng/ml), or deficiency ( < 50 nmol/L; 20 ng/ml). NAFLD was diagnosed at ultrasound examination and graded 0-3.
RESULTS: NAFLD was present in 57 patients (29.5%): 51 grade 1, 5 grade 2, and 1 grade 3. Median 25(OH)D levels were 53 nmol/L (IQR 38-70) in patients with NAFLD and 50 nmol/L (34-69) in patients without (p = 0.46). At multivariable analysis, NAFLD was not associated with 25(OH)D levels (p = 0.42) or vitamin D deficiency (p = 0.55), while BMI (OR 1.16, 95% CI 1.07-1.27) and serum triglycerides (OR 1.02, 95% CI 1.01-1.03) were independently associated with NAFLD.
CONCLUSIONS: Vitamin D status appears to have no link with low-grade NAFLD in patients with type 1 diabetes.

Entities:  

Keywords:  Non-alcoholic fatty liver disease (NAFLD); Type 1 diabetes; Ultrasound; Vitamin D

Mesh:

Substances:

Year:  2019        PMID: 30847862     DOI: 10.1007/s40618-019-01031-8

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  43 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Sonographic evaluation of visceral fat by measuring para- and perirenal fat.

Authors:  Satsuki Kawasaki; Kazutaka Aoki; Osamu Hasegawa; Kazushi Numata; Katsuaki Tanaka; Naomi Shibata; Sumiko Shimada; Atsushi Okamura; Yasuo Terauchi
Journal:  J Clin Ultrasound       Date:  2008 Mar-Apr       Impact factor: 0.910

3.  Perihepatic adipose tissue thickness: a new non-invasive marker of NAFLD?

Authors:  Flavio Lirussi; Nicola Vitturi; Lorenzo Azzalini; Serena Orando; Rocco Orlando; Mario Plebani; Giuseppe Realdi
Journal:  J Gastrointestin Liver Dis       Date:  2009-03       Impact factor: 2.008

4.  Sonographic measurement of the thickness of subcutaneous tissues in nonalcoholic fatty liver disease versus other chronic liver diseases.

Authors:  Thomas R Riley; Michael A Bruno
Journal:  J Clin Ultrasound       Date:  2005-12       Impact factor: 0.910

5.  Correlation of renal histopathology with sonographic findings.

Authors:  Sammy Moghazi; Edria Jones; Jill Schroepple; Kraisith Arya; William McClellan; Randolph A Hennigar; W Charles O'Neill
Journal:  Kidney Int       Date:  2005-04       Impact factor: 10.612

6.  Abnormal liver function tests in patients with Type 1 diabetes mellitus: prevalence, clinical correlations and underlying pathologies.

Authors:  J S Leeds; E M Forman; S Morley; A R Scott; S Tesfaye; D S Sanders
Journal:  Diabet Med       Date:  2009-12       Impact factor: 4.359

7.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

8.  Updated definitions of healthy ranges for serum alanine aminotransferase levels.

Authors:  Daniele Prati; Emanuela Taioli; Alberto Zanella; Emanuela Della Torre; Sonia Butelli; Emanuela Del Vecchio; Luciana Vianello; Francesco Zanuso; Fulvio Mozzi; Silvano Milani; Dario Conte; Massimo Colombo; Girolamo Sirchia
Journal:  Ann Intern Med       Date:  2002-07-02       Impact factor: 25.391

Review 9.  Fatty liver: a novel component of the metabolic syndrome.

Authors:  Anna Kotronen; Hannele Yki-Järvinen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-08-09       Impact factor: 8.311

10.  Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease.

Authors:  A E Joseph; S H Saverymuttu; S al-Sam; M G Cook; J D Maxwell
Journal:  Clin Radiol       Date:  1991-01       Impact factor: 2.350

View more
  2 in total

1.  Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Authors:  Marieke de Vries; Jan Westerink; Karin H A H Kaasjager; Harold W de Valk
Journal:  J Clin Endocrinol Metab       Date:  2020-12-01       Impact factor: 5.958

Review 2.  Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review.

Authors:  D Gallo; L Mortara; M B Gariboldi; S A M Cattaneo; S Rosetti; L Gentile; D M Noonan; P Premoli; C Cusini; M L Tanda; L Bartalena; E Piantanida
Journal:  J Endocrinol Invest       Date:  2019-10-04       Impact factor: 5.467

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.